PATENT CLAIM ANALYSIS

Application Number: 15776765
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["424", "499000"]

Abstract:
A multifunctional system in which a nanostructure (size range of about 10-1000 nm) degrades on exposure to an infection and its associated inflammatory milieu. The degraded nanostructures release the encapsulated drug during the process of degradation, where the kinetics of drug release is determined by the severity of the infection and inflammation. This degradation is triggered by proteases secreted by the pathogen, host polymorphonuclear leucocytes and other host cells. The nanostructures are conjugated to anti-TLR (Toll-like receptor) ligands for targeting the corneal epithelium and blocking the inflammatory pathway.

Claim (Index 15):
A pharmaceutical composition comprising a nanostructure based drug delivery system as claimed in  claim 1 .

Metadata:
- Claim Count in Document: 19.0
- Percentile: 93.0
- Lexical Diversity: 1.46269
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14420295', '14394147', '13636900', '12997444', '15434971']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6927674956978231
- 35 USC 102 Novelty (BERT): 0.5032778657214758
- Combined Prediction Score: 0.6738185327001884
- Mean Citation Score: 215.33550800000003
- Max Citation Score: 230.64055
- Similarity Product: 147.44099502208232

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test